Skip to content

The Beauty Health Company SKIN Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount at other companies

PDE
Pro-Dex, Inc.PDEX
$0-100%
Helen Of Troy logo
Helen Of TroyHELE

Other financials

Income statement

See full
Revenue$64.9M-6.7%
Gross profit$44.4M-8.5%
Operating income-$1.8M+85.0%
Net income-$6.6M+34.3%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$204.4M-45.2%
Total debt$125.9M+756%
Total equity$55.2M+19.9%
Total assets$473.2M-29.8%

Cash flow

See full
Operating cash flow-$5.6M-285%
CapEx$224.0K+398%
Free cash flow-$5.8M-296%

Valuation

See full
Market cap$89.75M-61.5%
Enterprise value$11.24M-96.2%
P/S0.3×-0.4×

Profitability

See full
Gross margin64.9%+8.3pp
Operating margin-3.6%-1.6pp
Net margin-2%-0.9pp
FCF margin9.6%

Returns & leverage

See full
Return on equity-12%-5.4pp
Debt / equity2.3×+2.0×
Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount.

The official record: The Beauty Health Company’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's valuation allowance, deferred tax asset, increase (decrease), amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Beauty Health Company's valuation allowance, deferred tax asset, increase (decrease), amount?
The Beauty Health Company (SKIN) reported valuation allowance, deferred tax asset, increase (decrease), amount of $150K in Q4 2025.
How has The Beauty Health Company's valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
The Beauty Health Company's valuation allowance, deferred tax asset, increase (decrease), amount decreased by 40.0% year-over-year, from $250K to $150K.
What is the long-term trend for The Beauty Health Company's valuation allowance, deferred tax asset, increase (decrease), amount?
Over 4 years (2021 to 2025), The Beauty Health Company's valuation allowance, deferred tax asset, increase (decrease), amount has grown at a -48.5% compound annual growth rate (CAGR), from $8.5M to $600K.
What does valuation allowance, deferred tax asset, increase (decrease), amount mean?
Tracks the net increase or decrease in the valuation allowance for deferred tax assets, which is a contra-asset account. It serves as a key indicator of management's confidence in utilizing tax benefits to offset future tax liabilities.